1 1506 102 IRRITABLE BOWEL SYNDROME: YOGA AS REMEDIAL THERAPY. IRRITABLE BOWEL SYNDROME (IBS) IS A GROUP OF SYMPTOMS MANIFESTING AS A FUNCTIONAL GASTROINTESTINAL (GI) DISORDER IN WHICH PATIENTS EXPERIENCE ABDOMINAL PAIN, DISCOMFORT, AND BLOATING THAT IS OFTEN RELIEVED WITH DEFECATION. IBS IS OFTEN ASSOCIATED WITH A HOST OF SECONDARY COMORBIDITIES SUCH AS ANXIETY, DEPRESSION, HEADACHES, AND FATIGUE. IN THIS REVIEW, WE EXAMINED THE BASIC PRINCIPLES OF PANCHA KOSHA (FIVE SHEATHS OF HUMAN EXISTENCE) CONCEPT FROM AN INDIAN SCRIPTURE TAITTIRIYA UPANISHAD AND THE PATHOPHYSIOLOGY OF A DISEASE FROM THE YOGA APPROACH, YOGA VASISTHA'S ADHI (ORIGINATED FROM MIND) AND VYADHI (AILMENT/DISEASE) CONCEPT. AN ANALOGY BETWEEN THE AGE OLD, THE MOST PROFOUND CONCEPT OF ADHI-VYADHI, AND MODERN SCIENTIFIC STRESS-INDUCED DYSREGULATION OF BRAIN-GUT AXIS, AS IT RELATES TO IBS THAT COULD PAVE WAY FOR IMPACTING IBS, IS EMPHASIZED. BASED ON THESE PERSPECTIVES, A PLAUSIBLE YOGA MODULE AS A REMEDIAL THERAPY IS PROVIDED TO BETTER MANAGE THE PRIMARY AND SECONDARY SYMPTOMS OF IBS. 2015 2 1917 17 ROLE OF YOGA AND ITS PLAUSIBLE MECHANISM IN THE MITIGATION OF DNA DAMAGE IN TYPE-2 DIABETES: A RANDOMIZED CLINICAL TRIAL. BACKGROUND: ALTHOUGH YOGA IS FOUND TO BE BENEFICIAL IN THE MANAGEMENT OF TYPE 2 DIABETES (T2D), ITS MECHANISM OF ACTION IS POORLY UNDERSTOOD. T2D IS ALSO KNOWN TO BE ASSOCIATED WITH INCREASED OXIDATIVE STRESS (OS) AND DNA DAMAGE. PURPOSE: THIS STUDY EXAMINES HOW YOGA MODULATES OS-INDUCED DNA DAMAGE AND THE EFFICIENCY OF DNA REPAIR IN T2D CONDITIONS. METHODS: IN THIS ASSESSOR-MASKED RANDOMIZED CLINICAL TRIAL, T2D SUBJECTS (N = 61), AGED (MEAN +/- SD, 50.3 +/- 4.2) WERE RANDOMLY ALLOCATED INTO YOGA GROUP (31) THAT RECEIVED 10 WEEKS OF YOGA INTERVENTION AND CONTROL (30) WITH ROUTINE EXERCISES. MOLECULAR AND BIOCHEMICAL ASSESSMENTS WERE DONE BEFORE AND AFTER THE INTERVENTION PERIOD. STRUCTURAL EQUATION MODELING USING "R" WAS USED FOR MEDIATION ANALYSIS. RESULTS: AT THE END OF THE 10TH WEEK, YOGA GROUP SHOWED SIGNIFICANT REDUCTION IN DNA DAMAGE INDICATORS LIKE TAIL MOMENT (-5.88[95%CI: -10.47 TO -1.30]; P = .013) AND OLIVE TAIL MOMENT (-2.93[95%CI: -4.87 TO -1.00]; P < .01), OXIDATIVE DNA DAMAGE MARKER 8-OHDG (-60.39[95%CI: -92.55 TO -28.23]; P < .001) AND FASTING BLOOD SUGAR (-22.58[95%CI: -44.33 TO -0.83]; P = .042) COMPARED TO CONTROL. OGG1 PROTEIN EXPRESSION INDICATING DNA REPAIR, IMPROVED SIGNIFICANTLY (17.55[95%CI:1.37 TO 33.73]; P = .034) WHEREAS TOTAL ANTIOXIDANT CAPACITY DID NOT (5.80[95%CI: -0.86 TO 12.47]; P = 0.086). MEDIATION ANALYSIS INDICATED THAT IMPROVEMENTS IN OXIDATIVE DNA DAMAGE AND DNA REPAIR TOGETHER PLAYED A MAJOR MEDIATORY ROLE (97.4%) IN CARRYING THE EFFECT OF YOGA. CONCLUSION: THE BENEFICIAL EFFECT OF YOGA ON DNA DAMAGE IN T2D SUBJECTS WAS FOUND TO BE MEDIATED BY MITIGATION OF OXIDATIVE DNA DAMAGE AND ENHANCEMENT OF DNA REPAIR. CLINICAL TRIAL INFORMATION: (WWW.CTRI.NIC.IN) CTRI/2018/07/014825. 2022 3 2567 24 YOGA FOR DEPRESSION AND ANXIETY: A REVIEW OF PUBLISHED RESEARCH AND IMPLICATIONS FOR HEALTHCARE PROVIDERS. THERE IS INCREASING INTEREST IN THE USE OF YOGA AS WAY TO MANAGE OR TREAT DEPRESSION AND ANXIETY. YOGA IS AFFORD- ABLE, APPEALING, AND ACCESSIBLE FOR MANY PEOPLE, AND THERE ARE PLAUSIBLE COGNITIVE/AFFECTIVE AND BIOLOGIC MECHANISMS BY WHICH YOGA COULD HAVE A POSITIVE IMPACT ON DEPRESSION AND ANXIETY. THERE IS INDEED PRELIMINARY EVIDENCE THAT YOGA MAY BE HELPFUL FOR THESE PROBLEMS, AND THERE ARE SEVERAL ONGOING LARGER-SCALE RANDOMIZED CLINICAL TRIALS. THE CURRENT EVIDENCE BASE IS STRONGEST FOR YOGA AS EFFICACIOUS IN REDUCING SYMPTOMS OF UNIPOLAR DEPRESSION. HOWEVER, THERE MAY BE RISKS TO ENGAGING IN YOGA AS WELL. HEALTHCARE PROVIDERS CAN HELP PATIENTS EVALUATE WHETHER A PARTICULAR COMMUNITY-BASED YOGA CLASS IS HELPFUL AND SAFE FOR THEM. 2016 4 1300 26 HATHA YOGA FOR DEPRESSION: CRITICAL REVIEW OF THE EVIDENCE FOR EFFICACY, PLAUSIBLE MECHANISMS OF ACTION, AND DIRECTIONS FOR FUTURE RESEARCH. BACKGROUND: THE PURPOSE OF THIS ARTICLE IS TO REVIEW THE EVIDENCE FOR THE EFFICACY OF HATHA YOGA FOR DEPRESSION AND POSSIBLE MECHANISMS BY WHICH YOGA MAY HAVE AN IMPACT ON DEPRESSION, AND TO OUTLINE DIRECTIONS FOR FUTURE RESEARCH. METHODS: LITERATURE REVIEW AND SYNTHESIS. RESULTS AND CONCLUSIONS: A LITERATURE SEARCH FOR CLINICAL TRIALS EXAMINING YOGA FOR DEPRESSION UNCOVERED EIGHT TRIALS: 5 INCLUDING INDIVIDUALS WITH CLINICAL DEPRESSION, AND 3 FOR INDIVIDUALS WITH ELEVATED DEPRESSION SYMPTOMS. ALTHOUGH RESULTS FROM THESE TRIALS ARE ENCOURAGING, THEY SHOULD BE VIEWED AS VERY PRELIMINARY BECAUSE THE TRIALS, AS A GROUP, SUFFERED FROM SUBSTANTIAL METHODOLOGICAL LIMITATIONS. WE WOULD ARGUE, HOWEVER, THAT THERE ARE SEVERAL REASONS TO CONSIDER CONSTRUCTING CAREFUL RESEARCH ON YOGA FOR DEPRESSION. FIRST, CURRENT STRATEGIES FOR TREATING DEPRESSION ARE NOT SUFFICIENT FOR MANY INDIVIDUALS, AND PATIENTS HAVE SEVERAL CONCERNS ABOUT EXISTING TREATMENTS. YOGA MAY BE AN ATTRACTIVE ALTERNATIVE TO OR A GOOD WAY TO AUGMENT CURRENT DEPRESSION TREATMENT STRATEGIES. SECOND, ASPECTS OF YOGA-INCLUDING MINDFULNESS PROMOTION AND EXERCISE-ARE THOUGHT TO BE "ACTIVE INGREDIENTS" OF OTHER SUCCESSFUL TREATMENTS FOR DEPRESSION. THIRD, THERE ARE PLAUSIBLE BIOLOGICAL, PSYCHOLOGICAL, AND BEHAVIORAL MECHANISMS BY WHICH YOGA MAY HAVE AN IMPACT ON DEPRESSION. WE PROVIDE SUGGESTIONS FOR THE NEXT STEPS IN THE STUDY OF YOGA AS A TREATMENT FOR DEPRESSION. 2010 5 2001 21 STRESS, INFLAMMATION, AND YOGA PRACTICE. OBJECTIVE: TO ADDRESS THE MECHANISMS UNDERLYING HATHA YOGA'S POTENTIAL STRESS-REDUCTION BENEFITS, WE COMPARED INFLAMMATORY AND ENDOCRINE RESPONSES OF NOVICE AND EXPERT YOGA PRACTITIONERS BEFORE, DURING, AND AFTER A RESTORATIVE HATHA YOGA SESSION, AS WELL AS IN TWO CONTROL CONDITIONS. STRESSORS BEFORE EACH OF THE THREE CONDITIONS PROVIDED DATA ON THE EXTENT TO WHICH YOGA SPEEDED AN INDIVIDUAL'S PHYSIOLOGICAL RECOVERY. METHODS: A TOTAL OF 50 HEALTHY WOMEN (MEAN AGE, 41.32 YEARS; RANGE, 30-65 YEARS), 25 NOVICES AND 25 EXPERTS, WERE EXPOSED TO EACH OF THE CONDITIONS (YOGA, MOVEMENT CONTROL, AND PASSIVE-VIDEO CONTROL) DURING THREE SEPARATE VISITS. RESULTS: THE YOGA SESSION BOOSTED PARTICIPANTS' POSITIVE AFFECT COMPARED WITH THE CONTROL CONDITIONS, BUT NO OVERALL DIFFERENCES IN INFLAMMATORY OR ENDOCRINE RESPONSES WERE UNIQUE TO THE YOGA SESSION. IMPORTANTLY, EVEN THOUGH NOVICES AND EXPERTS DID NOT DIFFER ON KEY DIMENSIONS, INCLUDING AGE, ABDOMINAL ADIPOSITY, AND CARDIORESPIRATORY FITNESS, NOVICES' SERUM INTERLEUKIN (IL)-6 LEVELS WERE 41% HIGHER THAN THOSE OF EXPERTS ACROSS SESSIONS, AND THE ODDS OF A NOVICE HAVING DETECTABLE C-REACTIVE PROTEIN (CRP) WERE 4.75 TIMES AS HIGH AS THAT OF AN EXPERT. DIFFERENCES IN STRESS RESPONSES BETWEEN EXPERTS AND NOVICES PROVIDED ONE PLAUSIBLE MECHANISM FOR THEIR DIVERGENT SERUM IL-6 DATA; EXPERTS PRODUCED LESS LIPOPOLYSACCHARIDE-STIMULATED IL-6 IN RESPONSE TO THE STRESSOR THAN NOVICES, AND IL-6 PROMOTES CRP PRODUCTION. CONCLUSION: THE ABILITY TO MINIMIZE INFLAMMATORY RESPONSES TO STRESSFUL ENCOUNTERS INFLUENCES THE BURDEN THAT STRESSORS PLACE ON AN INDIVIDUAL. IF YOGA DAMPENS OR LIMITS STRESS-RELATED CHANGES, THEN REGULAR PRACTICE COULD HAVE SUBSTANTIAL HEALTH BENEFITS. 2010 6 2540 25 YOGA FOR ANXIETY: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS. YOGA HAS BECOME A POPULAR APPROACH TO IMPROVE EMOTIONAL HEALTH. THE AIM OF THIS REVIEW WAS TO SYSTEMATICALLY ASSESS AND META-ANALYZE THE EFFECTIVENESS AND SAFETY OF YOGA FOR ANXIETY. MEDLINE/PUBMED, SCOPUS, THE COCHRANE LIBRARY, PSYCINFO, AND INDMED WERE SEARCHED THROUGH OCTOBER 2016 FOR RANDOMIZED CONTROLLED TRIALS (RCTS) OF YOGA FOR INDIVIDUALS WITH ANXIETY DISORDERS OR ELEVATED LEVELS OF ANXIETY. THE PRIMARY OUTCOMES WERE ANXIETY AND REMISSION RATES, AND SECONDARY OUTCOMES WERE DEPRESSION, QUALITY OF LIFE, AND SAFETY. RISK OF BIAS WAS ASSESSED USING THE COCHRANE TOOL. EIGHT RCTS WITH 319 PARTICIPANTS (MEAN AGE: 30.0-38.5 YEARS) WERE INCLUDED. RISK OF SELECTION BIAS WAS UNCLEAR FOR MOST RCTS. META-ANALYSES REVEALED EVIDENCE FOR SMALL SHORT-TERM EFFECTS OF YOGA ON ANXIETY COMPARED TO NO TREATMENT (STANDARDIZED MEAN DIFFERENCE [SMD] = -0.43; 95% CONFIDENCE INTERVAL [CI] = -0.74, -0.11; P = .008), AND LARGE EFFECTS COMPARED TO ACTIVE COMPARATORS (SMD = -0.86; 95% CI = -1.56, -0.15; P = .02). SMALL EFFECTS ON DEPRESSION WERE FOUND COMPARED TO NO TREATMENT (SMD = -0.35; 95% CI = -0.66, -0.04; P = .03). EFFECTS WERE ROBUST AGAINST POTENTIAL METHODOLOGICAL BIAS. NO EFFECTS WERE FOUND FOR PATIENTS WITH ANXIETY DISORDERS DIAGNOSED BY DIAGNOSTIC AND STATISTICAL MANUAL CRITERIA, ONLY FOR PATIENTS DIAGNOSED BY OTHER METHODS, AND FOR INDIVIDUALS WITH ELEVATED LEVELS OF ANXIETY WITHOUT A FORMAL DIAGNOSIS. ONLY THREE RCTS REPORTED SAFETY-RELATED DATA BUT THESE INDICATED THAT YOGA WAS NOT ASSOCIATED WITH INCREASED INJURIES. IN CONCLUSION, YOGA MIGHT BE AN EFFECTIVE AND SAFE INTERVENTION FOR INDIVIDUALS WITH ELEVATED LEVELS OF ANXIETY. THERE WAS INCONCLUSIVE EVIDENCE FOR EFFECTS OF YOGA IN ANXIETY DISORDERS. MORE HIGH-QUALITY STUDIES ARE NEEDED AND ARE WARRANTED GIVEN THESE PRELIMINARY FINDINGS AND PLAUSIBLE MECHANISMS OF ACTION. 2018 7 538 17 COMPLEMENTARY AND ALTERNATIVE TREATMENT FOR NECK PAIN: CHIROPRACTIC, ACUPUNCTURE, TENS, MASSAGE, YOGA, TAI CHI, AND FELDENKRAIS. OF THE MULTITUDE OF TREATMENT OPTIONS FOR THE MANAGEMENT OF NECK PAIN, NO OBVIOUS SINGLE TREATMENT MODALITY HAS BEEN SHOWN TO BE MOST EFFICACIOUS. AS SUCH, THE CLINICIAN SHOULD CONSIDER ALTERNATIVE TREATMENT MODALITIES IF A MODALITY IS ENGAGING, AVAILABLE, FINANCIALLY FEASIBLE, POTENTIALLY EFFICACIOUS, AND IS LOW RISK FOR THE PATIENT. AS EVIDENCE-BASED MEDICINE FOR NECK PAIN DEVELOPS, THE CLINICIAN IS FACED WITH THE CHALLENGE OF WHICH TREATMENTS TO ENCOURAGE PATIENTS TO PURSUE. TREATMENT MODALITIES EXPLORED IN THIS ARTICLE, INCLUDING CHIROPRACTIC, ACUPUNCTURE, TENS, MASSAGE, YOGA, TAI CHI, AND FELDENKRAIS, REPRESENT REASONABLE COMPLEMENTARY AND ALTERNATIVE MEDICINE METHODS FOR PATIENTS WITH NECK PAIN. 2011 8 576 21 DEPRESSION AND ANXIETY DISORDERS: BENEFITS OF EXERCISE, YOGA, AND MEDITATION. MANY PEOPLE WITH DEPRESSION OR ANXIETY TURN TO NONPHARMACOLOGIC AND NONCONVENTIONAL INTERVENTIONS, INCLUDING EXERCISE, YOGA, MEDITATION, TAI CHI, OR QI GONG. META-ANALYSES AND SYSTEMATIC REVIEWS HAVE SHOWN THAT THESE INTERVENTIONS CAN IMPROVE SYMPTOMS OF DEPRESSION AND ANXIETY DISORDERS. AS AN ADJUNCTIVE TREATMENT, EXERCISE SEEMS MOST HELPFUL FOR TREATMENT-RESISTANT DEPRESSION, UNIPOLAR DEPRESSION, AND POSTTRAUMATIC STRESS DISORDER. YOGA AS MONOTHERAPY OR ADJUNCTIVE THERAPY SHOWS POSITIVE EFFECTS, PARTICULARLY FOR DEPRESSION. AS AN ADJUNCTIVE THERAPY, IT FACILITATES TREATMENT OF ANXIETY DISORDERS, PARTICULARLY PANIC DISORDER. TAI CHI AND QI GONG MAY BE HELPFUL AS ADJUNCTIVE THERAPIES FOR DEPRESSION, BUT EFFECTS ARE INCONSISTENT. AS MONOTHERAPY OR AN ADJUNCTIVE THERAPY, MINDFULNESS-BASED MEDITATION HAS POSITIVE EFFECTS ON DEPRESSION, AND ITS EFFECTS CAN LAST FOR SIX MONTHS OR MORE. ALTHOUGH POSITIVE FINDINGS ARE LESS COMMON IN PEOPLE WITH ANXIETY DISORDERS, THE EVIDENCE SUPPORTS ADJUNCTIVE USE. THERE ARE NO APPARENT NEGATIVE EFFECTS OF MINDFULNESS-BASED INTERVENTIONS, AND THEIR GENERAL HEALTH BENEFITS JUSTIFY THEIR USE AS ADJUNCTIVE THERAPY FOR PATIENTS WITH DEPRESSION AND ANXIETY DISORDERS. 2019 9 2927 21 [YOGA FOR MENTAL DISORDERS]. BACKGROUND: THE DEMAND FOR COMPLEMENTARY CLINICALLY EFFICACIOUS, SAFE, PATIENT ACCEPTABLE, AND COST-EFFECTIVE FORMS OF TREATMENT FOR MENTAL ILLNESS IS GROWING. YOGA HAS BENEFICIAL EFFECTS ON SOMATIC AND MENTAL HEALTH FACTORS; THEREFORE, YOGA HAS PREVENTIVE AND THERAPEUTIC CAPABILITIES TO IMPROVE MENTAL DYSFUNCTION. OBJECTIVE: IN THIS OVERVIEW OF THE CURRENT LITERATURE, THE EVIDENCE OF THE EFFECTS OF YOGA ON SELECTED MAJOR PSYCHIATRIC DISORDERS IS SUMMARIZED. RESULTS: THE STRONGEST EVIDENCE BASE FOR YOGA EXISTS IN REDUCING DEPRESSIVE SYMPTOMS BUT ITS USE IN MAJOR DEPRESSIVE DISORDERS IS LESS CLEAR. THE EVIDENCE FOR THE EFFICACY OF YOGA FOR ANXIETY DISORDERS, AND POSTTRAUMATIC STRESS DISORDER (PTSD) IS ENCOURAGING, BUT NOT DEFINITIVE DUE TO ONLY A FEW RANDOMIZED CONTROLLED TRIALS AND METHODOLOGICAL PROBLEMS. CONCLUSION: THERE IS PRELIMINARY EVIDENCE THAT MEDITATION-BASED YOGA INTERVENTIONS MAY BE HELPFUL FOR DEPRESSION, ANXIETY AND PTSD; HOWEVER, THERE MAY ALSO BE THE RISK OF ENGAGING IN EXTREME YOGA PRACTICES. THE VALUE OF INTEGRATING YOGA INTO A TREATMENT PLAN FOR PATIENTS WITH PSYCHIATRIC DISORDERS NEEDS TO BE EVALUATED ON AN INDIVIDUAL BASIS. HEALTHCARE PROVIDERS CAN MOTIVATE AND HELP PATIENTS EVALUATE WHETHER A GIVEN YOGA CLASS IS HELPFUL AND SAFE FOR THEM. METHODOLOGICAL PROBLEMS AND THE UNCLEAR RISK-BENEFIT RATIO PRECLUDE DEFINITIVE RECOMMENDATIONS FOR YOGA AS AN ADJUNCT TREATMENT. 2018 10 2454 22 YOGA AS A COMPLEMENTARY THERAPY FOR METABOLIC SYNDROME: A NARRATIVE REVIEW. METABOLIC SYNDROME (MS) IS ASSOCIATED WITH A SEDENTARY AND STRESSFUL LIFESTYLE AND AFFECTS UNDERACTIVE PEOPLE DISPROPORTIONATELY. YOGA IS CONSIDERED TO BE A LOW-IMPACT MIND-BODY STRESS-RELIEVING EXERCISE, AND RESEARCHERS ARE INCREASING THEIR FOCUS ON THE BENEFITS OF YOGA FOR MANAGING METABOLIC DISORDERS. IT IS ALSO IMPORTANT FOR PHYSICIANS AND HEALTH CARE PROFESSIONALS TO UNDERSTAND THE THERAPEUTIC EFFICACY OF YOGA INTERVENTION, IN TERMS OF ITS TYPE, DURATION AND FREQUENCY ON VARIOUS MS RISK FACTORS. THE PRESENT REVIEW SUMMARIZES THE CURRENT SCIENTIFIC UNDERSTANDING OF THE EFFECTS OF YOGA ON MS RISK FACTORS SUCH AS GLUCOSE HOMEOSTASIS MARKERS, LIPID PROFILE, ADIPOCYTOKINES AND CARDIOVASCULAR RISK FACTORS, AND DISCUSSES THE POSSIBLE MECHANISMS OF ACTION. MEDLINE, PUBMED, SCOPUS AND COCHRANE LIBRARY WERE SEARCHED FROM THEIR INCEPTION UP TO DECEMBER 2019, USING THE KEYWORDS "METABOLIC SYNDROME," "DIABETES," "CARDIOVASCULAR DISEASES," "OBESITY" AND "YOGA." THE LITERATURE SUMMARIZED IN THIS REVIEW HAVE SHOWN MIXED EFFECTS OF YOGA ON MS RISK FACTORS AND DO NOT PROVIDE ROBUST EVIDENCE FOR ITS EFFICACY. MORE RIGOROUS RESEARCH AND WELL-DESIGNED TRIALS THAT HAVE A HIGHER STANDARD OF METHODOLOGY AND EVALUATE YOGA'S LONG-TERM IMPACTS ON MS ARE NEEDED. UNDERSTANDING YOGA'S BIOCHEMICAL AND MOLECULAR MECHANISMS OF ACTION ON VARIOUS METABOLIC PATHWAYS IS ALSO NEEDED. 2021 11 2445 15 YOGA AND SUBSTANCE USE DISORDERS: A NARRATIVE REVIEW. YOGA HAS BEEN UTILIZED FOR PROMOTION OF HEALTH AND ALLEVIATING DISTRESS. IT HAS ALSO BEEN USED AS A THERAPEUTIC MEASURE IN THE FIELD OF MENTAL HEALTH, INCLUDING SUBSTANCE USE DISORDERS. THIS NARRATIVE REVIEW DISCUSSES THE LITERATURE PERTAINING TO USE OF YOGA IN THE TREATMENT OF SUBSTANCE USE DISORDERS. THE EVIDENCE BASE ESPECIALLY WITH REGARDS TO RANDOMIZED TRIALS IS PRESENTED. THE POSSIBLE MECHANISMS HOW YOGA MIGHT BE HELPFUL IN THE TREATMENT OF SUBSTANCE USE DISORDERS ARE EXPLORED. SUBSEQUENTLY, IMPLICATIONS OF YOGA IN CLINICAL PRACTICE ARE ELABORATED, FOLLOWED BY EXAMINATION OF THE ISSUES IN INTERPRETATION OF THE LITERATURE OF PUBLISHED YOGA RELATED STUDIES. 2017 12 1186 25 EVIDENCE BASED EFFECTS OF YOGA IN NEUROLOGICAL DISORDERS. THOUGH YOGA IS ONE OF THE WIDELY USED MIND-BODY MEDICINE FOR HEALTH PROMOTION, DISEASE PREVENTION AND AS A POSSIBLE TREATMENT MODALITY FOR NEUROLOGICAL DISORDERS, THERE IS A LACK OF EVIDENCE-BASED REVIEW. HENCE, WE PERFORMED A COMPREHENSIVE SEARCH IN THE PUBMED/MEDLINE ELECTRONIC DATABASE TO REVIEW RELEVANT ARTICLES IN ENGLISH, USING KEYWORDS "YOGA AND NEUROLOGICAL DISORDER, YOGA AND MULTIPLE SCLEROSIS, YOGA AND STROKE, YOGA AND EPILEPSY, YOGA AND PARKINSON'S DISEASE, YOGA AND DEMENTIA, YOGA AND CEREBROVASCULAR DISEASE, YOGA AND ALZHEIMER DISEASE, YOGA AND NEUROPATHY, YOGA AND MYELOPATHY, AND YOGA AND GUILLAIN-BARRE SYNDROME". A TOTAL OF 700 ARTICLES PUBLISHED FROM 1963 TO 14TH DECEMBER 2016 WERE AVAILABLE. OF 700 ARTICLES, 94 ARTICLES WERE INCLUDED IN THIS REVIEW. BASED ON THE AVAILABLE LITERATURE, IT COULD BE CONCLUDED THAT YOGA MIGHT BE CONSIDERED AS AN EFFECTIVE ADJUVANT FOR THE PATIENTS WITH VARIOUS NEUROLOGICAL DISORDERS. 2017 13 2297 17 THERAPEUTIC ROLE OF YOGA IN NEUROPSYCHOLOGICAL DISORDERS. YOGA IS CONSIDERED A WIDELY-USED APPROACH FOR HEALTH CONSERVATION AND CAN BE ADOPTED AS A TREATMENT MODALITY FOR A PLETHORA OF MEDICAL CONDITIONS, INCLUDING NEUROLOGICAL AND PSYCHOLOGICAL DISORDERS. HENCE, WE REVIEWED RELEVANT ARTICLES ENTAILING VARIOUS NEUROLOGICAL AND PSYCHOLOGICAL DISORDERS AND GATHERED DATA ON HOW YOGA EXERTS POSITIVE IMPACTS ON PATIENTS WITH A DIVERSE RANGE OF DISORDERS, INCLUDING ITS MODULATORY EFFECTS ON BRAIN BIOELECTRICAL ACTIVITIES, NEUROTRANSMITTERS, AND SYNAPTIC PLASTICITY. THE ROLE OF YOGA PRACTICE AS AN ELEMENT OF THE TREATMENT OF SEVERAL NEUROPSYCHOLOGICAL DISEASES WAS EVALUATED BASED ON THESE FINDINGS. 2021 14 2541 19 YOGA FOR ANXIETY: A SYSTEMATIC REVIEW OF THE RESEARCH EVIDENCE. BETWEEN MARCH AND JUNE 2004, A SYSTEMATIC REVIEW WAS CARRIED OUT OF THE RESEARCH EVIDENCE ON THE EFFECTIVENESS OF YOGA FOR THE TREATMENT OF ANXIETY AND ANXIETY DISORDERS. EIGHT STUDIES WERE REVIEWED. THEY REPORTED POSITIVE RESULTS, ALTHOUGH THERE WERE MANY METHODOLOGICAL INADEQUACIES. OWING TO THE DIVERSITY OF CONDITIONS TREATED AND POOR QUALITY OF MOST OF THE STUDIES, IT IS NOT POSSIBLE TO SAY THAT YOGA IS EFFECTIVE IN TREATING ANXIETY OR ANXIETY DISORDERS IN GENERAL. HOWEVER, THERE ARE ENCOURAGING RESULTS, PARTICULARLY WITH OBSESSIVE COMPULSIVE DISORDER. FURTHER WELL CONDUCTED RESEARCH IS NECESSARY WHICH MAY BE MOST PRODUCTIVE IF FOCUSED ON SPECIFIC ANXIETY DISORDERS. 2005 15 1069 22 EFFECTS OF YOGA ON MENTAL AND PHYSICAL HEALTH: A SHORT SUMMARY OF REVIEWS. THIS REPORT SUMMARIZES THE CURRENT EVIDENCE ON THE EFFECTS OF YOGA INTERVENTIONS ON VARIOUS COMPONENTS OF MENTAL AND PHYSICAL HEALTH, BY FOCUSSING ON THE EVIDENCE DESCRIBED IN REVIEW ARTICLES. COLLECTIVELY, THESE REVIEWS SUGGEST A NUMBER OF AREAS WHERE YOGA MAY WELL BE BENEFICIAL, BUT MORE RESEARCH IS REQUIRED FOR VIRTUALLY ALL OF THEM TO FIRMLY ESTABLISH SUCH BENEFITS. THE HETEROGENEITY AMONG INTERVENTIONS AND CONDITIONS STUDIED HAS HAMPERED THE USE OF META-ANALYSIS AS AN APPROPRIATE TOOL FOR SUMMARIZING THE CURRENT LITERATURE. NEVERTHELESS, THERE ARE SOME META-ANALYSES WHICH INDICATE BENEFICIAL EFFECTS OF YOGA INTERVENTIONS, AND THERE ARE SEVERAL RANDOMIZED CLINICAL TRIALS (RCT'S) OF RELATIVELY HIGH QUALITY INDICATING BENEFICIAL EFFECTS OF YOGA FOR PAIN-ASSOCIATED DISABILITY AND MENTAL HEALTH. YOGA MAY WELL BE EFFECTIVE AS A SUPPORTIVE ADJUNCT TO MITIGATE SOME MEDICAL CONDITIONS, BUT NOT YET A PROVEN STAND-ALONE, CURATIVE TREATMENT. LARGER-SCALE AND MORE RIGOROUS RESEARCH WITH HIGHER METHODOLOGICAL QUALITY AND ADEQUATE CONTROL INTERVENTIONS IS HIGHLY ENCOURAGED BECAUSE YOGA MAY HAVE POTENTIAL TO BE IMPLEMENTED AS A BENEFICIAL SUPPORTIVE/ADJUNCT TREATMENT THAT IS RELATIVELY COST-EFFECTIVE, MAY BE PRACTICED AT LEAST IN PART AS A SELF-CARE BEHAVIORAL TREATMENT, PROVIDES A LIFE-LONG BEHAVIOURAL SKILL, ENHANCES SELF-EFFICACY AND SELF-CONFIDENCE AND IS OFTEN ASSOCIATED WITH ADDITIONAL POSITIVE SIDE EFFECTS. 2012 16 514 23 COMPARING AEROBIC EXERCISE WITH YOGA IN ANXIETY REDUCTION: AN INTEGRATIVE REVIEW. ANXIETY IS A COMMON MENTAL HEALTH DISORDER THAT AFFECTS MANY AMERICANS YET OFTEN GOES UNRECOGNIZED OR UNDERTREATED. THE PURPOSE OF THIS ARTICLE IS TO REVIEW THE CURRENT LITERATURE TO ASSIST IN DETERMINING WHICH ALTERNATIVE AND COMPLIMENTARY THERAPY, AEROBIC EXERCISE OR YOGA, IS MOST BENEFICIAL IN REDUCING ANXIETY SYMPTOMS. THE LITERATURE SEARCH PROCESS RESULTED IN A TOTAL OF 14 ARTICLES INCLUDED IN THE REVIEW. RESULTS INDICATE THAT YOGA IS MORE EFFECTIVE IN DECREASING ANXIETY SYMPTOMS THAN AEROBIC EXERCISE. HEALTH CARE PROVIDERS CAN USE THIS INFORMATION TO HELP RECOMMEND AN ALTERNATIVE FORM OF THERAPY FOR PATIENTS. 2022 17 2438 23 YOGA AND QIGONG IN THE PSYCHOLOGICAL PREVENTION OF MENTAL HEALTH DISORDERS: A CONCEPTUAL SYNTHESIS. THE STUDY PROPOSES TO EXPLORE TWO ALTERNATIVE MEDICINE THERAPIES-QIGONG AND YOGA FOR BALANCING THE ESSENTIAL DUO OF HOLISTIC MIND-BODY AND CONSEQUENTLY OFFER A SOLUTION FOR STRESS, UNCERTAINTY, ANXIETY AND DEPRESSION. QUALITATIVE RESEARCH METHODS HAVE BEEN USED TO CREATE A CONCEPTUAL SYNTHESIS OF YOGA AND QIGONG. IT IS SUGGESTED THAT AN INCREASED SENSE OF CONTROL IS THE INTERFACE BETWEEN THESE TWO MODALITIES. THIS CONCEPTUAL CONGRUENCE OF QIGONG AND YOGA IS THOUGHT TO BE A SELECTIVE, CURATIVE METHOD, A PRESCRIPTION FOR IDEAL LIVING AND A GROUND OF HUMAN ESSENCE EXISTENCE. FURTHERMORE, THIS ESSENCE IS THOUGHT TO ENHANCE THE MIND'S SELF-REGULATORY PROCESSES AND PREVENT MENTAL HEALTH DISORDERS. THE TWO ALTERNATIVE THERAPIES CAN PREVENT MENTAL HEALTH DISORDERS SUCH AS ANXIETY, DEPRESSION AND, MINIMIZE MENTAL HEALTH DISRUPTIONS SUCH AS STRESS AND POOR QUALITY OF LIFE. IT IS SUGGESTED THAT PATIENTS AND/OR CLIENTS CAN BENEFIT FROM THIS FUSION. 2010 18 1347 28 HYPOXIA IN CNS PATHOLOGIES: EMERGING ROLE OF MIRNA-BASED NEUROTHERAPEUTICS AND YOGA BASED ALTERNATIVE THERAPIES. CELLULAR RESPIRATION IS A VITAL PROCESS FOR THE EXISTENCE OF LIFE. ANY CONDITION THAT RESULTS IN DEPRIVATION OF OXYGEN (ALSO TERMED AS HYPOXIA) MAY EVENTUALLY LEAD TO DELETERIOUS EFFECTS ON THE FUNCTIONING OF TISSUES. BRAIN BEING THE HIGHEST CONSUMER OF OXYGEN IS PRONE TO INCREASED RISK OF HYPOXIA-INDUCED NEUROLOGICAL INSULTS. THIS IN TURN HAS BEEN ASSOCIATED WITH MANY DISEASES OF CENTRAL NERVOUS SYSTEM (CNS) SUCH AS STROKE, ALZHEIMER'S, ENCEPHALOPATHY ETC. ALTHOUGH SEVERAL STUDIES HAVE INVESTIGATED THE PATHOPHYSIOLOGICAL MECHANISMS UNDERLYING ISCHEMIC/HYPOXIC CNS DISEASES, THE KNOWLEDGE ABOUT PROTECTIVE THERAPEUTIC STRATEGIES TO AMELIORATE THE AFFECTED NEURONAL CELLS IS MEAGER. THIS HAS AUGMENTED THE NEED TO IMPROVE OUR UNDERSTANDING OF THE HYPOXIC AND ISCHEMIC EVENTS OCCURRING IN THE BRAIN AND IDENTIFY NOVEL AND ALTERNATE TREATMENT MODALITIES FOR SUCH INSULTS. MICRORNA (MIRNAS), SMALL NON-CODING RNA MOLECULES, HAVE RECENTLY EMERGED AS POTENTIAL NEUROPROTECTIVE AGENTS AS WELL AS TARGETS, UNDER HYPOXIC CONDITIONS. THESE 18-22 NUCLEOTIDE LONG RNA MOLECULES ARE PROFUSELY PRESENT IN BRAIN AND OTHER ORGANS AND FUNCTION AS GENE REGULATORS BY CLEAVING AND SILENCING THE GENE EXPRESSION. IN BRAIN, THESE ARE KNOWN TO BE INVOLVED IN NEURONAL DIFFERENTIATION AND PLASTICITY. THEREFORE, TARGETING MIRNA EXPRESSION REPRESENTS A NOVEL THERAPEUTIC APPROACH TO INTERCEDE AGAINST HYPOXIC AND ISCHEMIC BRAIN INJURY. IN THE FIRST PART OF THIS REVIEW, WE WILL DISCUSS THE NEUROPHYSIOLOGICAL CHANGES CAUSED AS A RESULT OF HYPOXIA, FOLLOWED BY THE CONTRIBUTION OF HYPOXIA IN THE NEURODEGENERATIVE DISEASES. SECONDLY, WE WILL PROVIDE RECENT UPDATES AND INSIGHTS INTO THE ROLES OF MIRNA IN THE REGULATION OF GENES IN OXYGEN AND GLUCOSE DEPRIVED BRAIN IN ASSOCIATION WITH CIRCADIAN RHYTHMS AND HOW THESE CAN BE TARGETED AS NEUROPROTECTIVE AGENTS FOR CNS INJURIES. FINALLY, WE WILL EMPHASIZE ON ALTERNATE BREATHING OR YOGIC INTERVENTIONS TO OVERCOME THE HYPOXIA ASSOCIATED ANOMALIES THAT COULD ULTIMATELY LEAD TO IMPROVEMENT IN CEREBRAL PERFUSION. 2017 19 225 21 A SYSTEMATIC REVIEW OF MECHANISMS OF CHANGE IN BODY-ORIENTED YOGA IN MAJOR DEPRESSIVE DISORDERS. INTRODUCTION: DESPITE EMPIRICAL EVIDENCE FOR THE EFFICACY OF BODY-ORIENTED YOGA AS ADD-ON TREATMENT FOR MAJOR DEPRESSIVE DISORDER (MDD), THE SPECIFIC MECHANISMS BY WHICH YOGA LEADS TO THERAPEUTIC CHANGES REMAIN UNCLEAR. BY MEANS OF A SYSTEMATIC REVIEW, WE EVALUATE HOW THE FIELD IS PROGRESSING IN ITS EMPIRICAL INVESTIGATION OF MECHANISMS OF CHANGE IN YOGA FOR MDD. METHODS: TO IDENTIFY RELEVANT STUDIES, A SYSTEMATIC SEARCH WAS CONDUCTED. RESULTS: THE SEARCH PRODUCED 441 ARTICLES, OF WHICH 5 WERE INCLUDED, THAT EMPIRICALLY EXAMINED 2 PSYCHOLOGICAL MECHANISMS (MINDFULNESS, RUMINATION) AND 3 BIOLOGICAL MECHANISMS (VAGAL CONTROL, HEART RATE VARIABILITY [HRV], BRAIN-DERIVED NEUROTROPHIC FACTOR [BDNF], CORTISOL). 2 STUDIES FOUND THAT DECREASED RUMINATION AND 1 STUDY THAT INCREASED MINDFULNESS WAS ASSOCIATED WITH THE EFFECT OF YOGA ON TREATMENT OUTCOME. IN ADDITION, PRELIMINARY STUDIES SUGGEST THAT ALTERATIONS IN CORTISOL, BDNF, AND HRV MAY PLAY A ROLE IN HOW YOGA EXERTS ITS CLINICAL EFFECT. DISCUSSION: THE RESULTS SUGGEST THAT BODY-ORIENTED YOGA COULD WORK THROUGH SOME OF THE THEORETICALLY PREDICTED MECHANISMS. HOWEVER, THERE IS A NEED FOR MORE RIGOROUS DESIGNS THAT CAN ASSESS GREATER LEVELS OF CAUSAL SPECIFICITY. 2018 20 2688 22 YOGA IN THE TREATMENT OF MOOD AND ANXIETY DISORDERS: A REVIEW. BACKGROUND: PATIENT USE OF COMPLEMENTARY AND ALTERNATIVE TREATMENTS, INCLUDING YOGA, TO MANAGE MOOD AND ANXIETY DISORDERS, HAS BEEN WELL DOCUMENTED. DESPITE RESEARCH INTEREST, THERE ARE FEW RECENT REVIEWS OF THE EVIDENCE OF THE BENEFIT OF YOGA IN THESE CONDITIONS. METHOD: THE PUBMED, MEDLINE AND PSYCINFO DATABASES WERE SEARCHED FOR LITERATURE PUBLISHED UP TO JULY 2008, RELATING TO YOGA AND DEPRESSIVE AND ANXIETY DISORDERS. RESULTS: THE PAUCITY OF REPORTED STUDIES AND SEVERAL METHODOLOGICAL CONSTRAINTS LIMIT DATA INTERPRETATION. IN DEPRESSIVE DISORDERS, YOGA MAY BE COMPARABLE TO MEDICATION AND THE COMBINATION SUPERIOR TO MEDICATION ALONE. THERE IS REASONABLE EVIDENCE FOR ITS USE AS SECOND-LINE MONOTHERAPY OR AUGMENTATION TO MEDICATION IN MILD TO MODERATE MAJOR DEPRESSION AND DYSTHYMIA, WITH EARLY EVIDENCE OF BENEFIT IN MORE SEVERE DEPRESSION. IN ANXIETY DISORDERS, YOGA MAY BE SUPERIOR TO MEDICATION FOR A SUBGROUP OF PATIENTS, BUT ITS BENEFITS IN SPECIFIC CONDITIONS ARE STILL LARGELY UNKNOWN. SECOND-LINE MONOTHERAPY IS INDICATED IN PERFORMANCE OR TEST ANXIETY, BUT ONLY PRELIMINARY EVIDENCE EXISTS FOR OBSESSIVE-COMPULSIVE DISORDER AND POST-TRAUMATIC STRESS DISORDER. YOGA APPEARS TO BE SUPERIOR TO NO TREATMENT AND PROGRESSIVE RELAXATION FOR BOTH DEPRESSION AND ANXIETY, AND MAY BENEFIT MOOD AND ANXIETY SYMPTOMS ASSOCIATED WITH MEDICAL ILLNESS. IT SHOWS GOOD SAFETY AND TOLERABILITY IN SHORT-TERM TREATMENT. CONCLUSION: REASONABLE EVIDENCE SUPPORTS THE BENEFIT OF YOGA IN SPECIFIC DEPRESSIVE DISORDERS. THE EVIDENCE IS STILL PRELIMINARY IN ANXIETY DISORDERS. GIVEN ITS PATIENT APPEAL AND THE PROMISING FINDINGS THUS FAR, FURTHER RESEARCH ON YOGA IN THESE CONDITIONS IS ENCOURAGED. 2009